Springer Nature is making SARS-CoV-2 and COVID-19 research free. View research | View latest news | Sign up for updates

Anticoagulant activity should be monitored after starting or changing celecoxib therapy in patients receiving warfarin

    • 4 Accesses

    This is a preview of subscription content, log in to check access.

    Rights and permissions

    Reprints and Permissions

    About this article

    Cite this article

    Anticoagulant activity should be monitored after starting or changing celecoxib therapy in patients receiving warfarin. React. Wkly. 754, 3 (1999). https://doi.org/10.2165/00128415-199907540-00005

    Download citation

    Keywords

    • Public Health
    • Elderly Patient
    • Warfarin
    • Prothrombin
    • Celecoxib